Literature DB >> 17105914

Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.

Frederico C Pereira1, Elita Lourenço, Nuno Milhazes, Teresa Morgadinho, Carlos F Ribeiro, Syed F Ali, Tice R Macedo.   

Abstract

The co-administration of methamphetamine (METH) and MOR (MOR)-like compounds is becoming increasingly popular among drug abusers. Recently, it was demonstrated that rats would self-inject METH-heroin combination and that this combination produced a greater rewarding effect than the identical doses of METH alone and it was further suggested that enhanced reward might underlie the popularity of this combination. However, there is null information on the effects of the MOR-METH combination on striatal dopaminergic transmission. In the present article, in vivo brain microdialysis was used to examine the effects of two METH doses (1 and 5 mg/kg, i.p.; [METH1: hyperlocomotion-inducing] and [METH5: stereotypy-inducing], respectively) and MOR (10 mg/kg, i.p. [MOR10]) either alone or in combination on dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) release in caudate putamen (CPu) in freely moving rats. METH1 evoked a transient threefold increase in DA overflow in only one-third of dosed rats. On the contrary, METH5 elicited a 11-fold increase in the extracellular DA levels 30 min after dosing and stayed significantly (P < 0.05) above control levels up to 1.5 h. On the other hand, MOR10 did not significantly change DA extracellular levels. MOR10-METH1 combination prolonged DA outflow for 1 h in all rats dosed without changing peak effect compared to METH1. On the other hand, MOR10-METH5 combination did not change the peak effect nor the DA outflow profile compared to METH5 alone. Consistently, there is a concentration-dependent decrease in DOPAC efflux evoked by METH: METH1 evoked a smaller decrease in DOPAC outflow showing a tendency for returning to basal values whereas METH5 kept DOPAC extracellular levels reduced throughout the experiment. Again, MOR10 did not significantly change DOPAC extracellular levels. MOR delayed the onset without changing METH effect on the DOPAC output. These findings provide suggestive evidence that MOR potentiated the increase in extracellular DA levels induced by a low dose of METH. Thus, this combination yields a profile of action that might underlie the reinforcing properties sought by drug addicts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105914     DOI: 10.1196/annals.1369.016

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.

Authors:  Daniel E Rusyniak; Dmitry V Zaretsky; Maria V Zaretskaia; Pamela J Durant; Joseph A DiMicco
Journal:  Physiol Behav       Date:  2012-02-14

3.  Activation of mu opioid receptors in the striatum differentially augments methamphetamine-induced gene expression and enhances stereotypic behavior.

Authors:  Kristen A Horner; John C Hebbard; Anna S Logan; Golda A Vanchipurakel; Yamiece E Gilbert
Journal:  J Neurochem       Date:  2012-01-23       Impact factor: 5.372

4.  The effect of concurrent access to alcohol and oxycodone on self-administration and reinstatement in rats.

Authors:  Kristen N Amico; Miranda E Arnold; Morgan S Dourron; Matthew G Solomon; Jesse R Schank
Journal:  Psychopharmacology (Berl)       Date:  2022-08-16       Impact factor: 4.415

5.  Hydrogen Sulfide Protects Hippocampal Neurons Against Methamphetamine Neurotoxicity Via Inhibition of Apoptosis and Neuroinflammation.

Authors:  Fateme Ghanbari; Mehdi Khaksari; Golamhassan Vaezi; Vida Hojati; Abdolhossein Shiravi
Journal:  J Mol Neurosci       Date:  2018-11-19       Impact factor: 3.444

6.  Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  Am J Addict       Date:  2009 Jan-Feb

7.  Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.

Authors:  Glen R Hanson; Amanda J Hoonakker; Christina M Robson; Lisa M McFadden; Paul S Frankel; Mario E Alburges
Journal:  J Pharmacol Exp Ther       Date:  2013-05-17       Impact factor: 4.030

8.  Buprenorphine modulates methamphetamine-induced dopamine dynamics in the rat caudate nucleus.

Authors:  Frederico C Pereira; Bobby Gough; Tice R Macedo; Carlos F Ribeiro; Syed F Ali; Zbigniew K Binienda
Journal:  Neurotox Res       Date:  2009-12-22       Impact factor: 3.911

9.  Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial.

Authors:  Alireza Noroozi; Seyed Abbas Motevalian; Mohammad-Reza Zarrindast; Javad Alaghband-Rad; Shahin Akhondzadeh
Journal:  Med J Islam Repub Iran       Date:  2020-10-14

10.  Dopamine D4 Receptor Is a Regulator of Morphine-Induced Plasticity in the Rat Dorsal Striatum.

Authors:  Alicia Rivera; Diana Suárez-Boomgaard; Cristina Miguelez; Alejandra Valderrama-Carvajal; Jérôme Baufreton; Kirill Shumilov; Anne Taupignon; Belén Gago; M Ángeles Real
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.